Shuttle Pharmaceuticals Inc (SHPH) Stock Analysis

Shuttle Pharmaceuticals Inc (SHPH) is a publicly traded company in the HEALTHCARE sector. It trades at $0.53, carries a market capitalization of $3.12M, a price-to-earnings ratio of 53.30. This page summarizes the public market data, fundamentals, and frequently asked questions for SHPH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Shuttle Pharmaceuticals Inc currently has a Neutral sentiment score of 0.07.

About Shuttle Pharmaceuticals Inc

Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the discovery and development of innovative therapeutic solutions that enhance the effectiveness of radiation therapy in cancer treatment. Through its subsidiary, Shuttle Pharmaceuticals, Inc., the company is dedicated to advancing its proprietary drug candidates designed to sensitize tumors to radiation, thereby improving patient outcomes. With a robust pipeline and a commitment to...

GNG Research Analysis

GNG Research scores Shuttle Pharmaceuticals Inc (SHPH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SHPH.

Frequently Asked Questions

Does SHPH pay dividends?

Shuttle Pharmaceuticals Inc (SHPH) does not currently pay a regular dividend.

What is SHPH's P/E ratio?

Shuttle Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 53.30.

What is SHPH's market cap?

Shuttle Pharmaceuticals Inc (SHPH) has a market capitalization of $3.12M with a current stock price of $0.53.